Vaxxinity Financial Statements From 2010 to 2024
| VAXX Stock | USD 0.13 0.07 33.70% |
Gross Profit -1.9 M | Market Capitalization 25.3 M | Enterprise Value Revenue 1.9 K | Revenue (1,000.00) | Earnings Share (0.45) |
Vaxxinity Total Revenue |
|
Check Vaxxinity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxxinity main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 1.6 M or Depreciation And Amortization of 2.3 M, as well as many exotic indicators such as Price To Sales Ratio of 5.8 K, Dividend Yield of 0.023 or PTB Ratio of 8.42. Vaxxinity financial statements analysis is a perfect complement when working with Vaxxinity Valuation or Volatility modules.
Vaxxinity | Select Account or Indicator |
Vaxxinity Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vaxxinity Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vaxxinity Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vaxxinity Valuation Data | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vaxxinity Fundamental Market Drivers
| Cash And Short Term Investments | 30.5 M |
Vaxxinity Upcoming Events
| 25th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 25th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
About Vaxxinity Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Vaxxinity income statement, its balance sheet, and the statement of cash flows. Vaxxinity investors use historical funamental indicators, such as Vaxxinity's revenue or net income, to determine how well the company is positioned to perform in the future. Although Vaxxinity investors may use each financial statement separately, they are all related. The changes in Vaxxinity's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vaxxinity's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Vaxxinity Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Vaxxinity. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Revenue | (1,000.00) | 0.00 | |
| Cost Of Revenue | 2.2 M | 1.3 M | |
| Stock Based Compensation To Revenue | 414.71 | 435.44 | |
| Sales General And Administrative To Revenue | 706.70 | 742.04 | |
| Research And Ddevelopement To Revenue | 973.35 | 1,022 | |
| Capex To Revenue | (22.97) | (24.11) | |
| Revenue Per Share | 0.0006 | 0.0006 | |
| Ebit Per Revenue | -2.2 K | -2.1 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vaxxinity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vaxxinity's short interest history, or implied volatility extrapolated from Vaxxinity options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vaxxinity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vaxxinity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaxxinity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vaxxinity Stock:Check out the analysis of Vaxxinity Correlation against competitors. For more information on how to buy Vaxxinity Stock please use our How to Invest in Vaxxinity guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Vaxxinity Stock analysis
When running Vaxxinity's price analysis, check to measure Vaxxinity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxxinity is operating at the current time. Most of Vaxxinity's value examination focuses on studying past and present price action to predict the probability of Vaxxinity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxxinity's price. Additionally, you may evaluate how the addition of Vaxxinity to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Vaxxinity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaxxinity. If investors know Vaxxinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaxxinity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.45) | Quarterly Revenue Growth (0.57) | Return On Assets (0.48) | Return On Equity (1.51) |
The market value of Vaxxinity is measured differently than its book value, which is the value of Vaxxinity that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxxinity's value that differs from its market value or its book value, called intrinsic value, which is Vaxxinity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxxinity's market value can be influenced by many factors that don't directly affect Vaxxinity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxxinity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxxinity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxxinity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.